1. Home
  2. TECH vs UMBF Comparison

TECH vs UMBF Comparison

Compare TECH & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • UMBF
  • Stock Information
  • Founded
  • TECH 1976
  • UMBF 1913
  • Country
  • TECH United States
  • UMBF United States
  • Employees
  • TECH N/A
  • UMBF N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • UMBF Major Banks
  • Sector
  • TECH Health Care
  • UMBF Finance
  • Exchange
  • TECH Nasdaq
  • UMBF Nasdaq
  • Market Cap
  • TECH 7.8B
  • UMBF 8.7B
  • IPO Year
  • TECH 1989
  • UMBF N/A
  • Fundamental
  • Price
  • TECH $57.09
  • UMBF $121.59
  • Analyst Decision
  • TECH Buy
  • UMBF Buy
  • Analyst Count
  • TECH 12
  • UMBF 9
  • Target Price
  • TECH $69.82
  • UMBF $133.22
  • AVG Volume (30 Days)
  • TECH 2.2M
  • UMBF 653.2K
  • Earning Date
  • TECH 08-06-2025
  • UMBF 07-29-2025
  • Dividend Yield
  • TECH 0.56%
  • UMBF 1.32%
  • EPS Growth
  • TECH N/A
  • UMBF 12.71
  • EPS
  • TECH 0.46
  • UMBF 8.74
  • Revenue
  • TECH $1,219,635,000.00
  • UMBF $1,949,350,000.00
  • Revenue This Year
  • TECH $7.33
  • UMBF $63.78
  • Revenue Next Year
  • TECH $9.32
  • UMBF $7.67
  • P/E Ratio
  • TECH $124.26
  • UMBF $13.92
  • Revenue Growth
  • TECH 5.23
  • UMBF 31.18
  • 52 Week Low
  • TECH $46.01
  • UMBF $82.00
  • 52 Week High
  • TECH $80.95
  • UMBF $129.94
  • Technical
  • Relative Strength Index (RSI)
  • TECH 60.85
  • UMBF 72.57
  • Support Level
  • TECH $53.89
  • UMBF $114.33
  • Resistance Level
  • TECH $54.95
  • UMBF $116.95
  • Average True Range (ATR)
  • TECH 1.93
  • UMBF 2.56
  • MACD
  • TECH 0.25
  • UMBF 0.58
  • Stochastic Oscillator
  • TECH 96.52
  • UMBF 97.85

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About UMBF UMB Financial Corporation

UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.

Share on Social Networks: